What are the typical CT (Computed Tomography) scan findings in a patient with suspected aspergilloma, particularly in those with pre-existing lung disease or an immunocompromised state?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Scan Findings in Aspergilloma

The classic CT finding of aspergilloma is a mobile mass with soft-tissue attenuation within a pre-existing lung cavity, separated from the cavity wall by an airspace creating the characteristic "air crescent sign" or "meniscus sign." 1, 2

Primary Imaging Modality

  • CT scan (preferably high-resolution CT with contrast) is the imaging modality of choice for diagnosing aspergilloma, providing superior definition and localization compared to chest radiographs 1, 2
  • Intravenous contrast administration (CT-angiography) is required at baseline, particularly to evaluate vascular structures and is essential if hemoptysis is present 1, 2
  • Chest radiographs remain useful for initial suspicion but have limited sensitivity for definitive diagnosis 2

Classic CT Findings

The Mobile Aspergilloma

  • Round or oval mass with soft-tissue attenuation within a pre-existing lung cavity 3, 4
  • Air crescent sign (meniscus sign): airspace of variable size and shape separating the fungal mass from the cavity wall 3, 4, 5
  • Mobility is easily demonstrated by obtaining images in both supine and prone positions, confirming the mass moves with gravity 5
  • Thickening of the cavity wall and adjacent pleura is commonly associated 3

The Fixed Aspergilloma

  • Irregular spongework pattern containing multiple air spaces filling the cavity, which obliterates the classic air crescent sign 5
  • This appearance represents a fixed, immobile fungus ball 5
  • Forming aspergillomas show fungal strands falling into the cavity lumen, trapping air and creating the initial sponge-work appearance 5

Technical Imaging Parameters

  • Use narrow (3-5 mm) sections with a bone algorithm and wide window settings to accurately identify both forming and mature aspergillomas 5
  • Sections should be obtained every 5-10 mm through the thorax 6
  • Lateral mobilizations (prone and supine positioning) help demonstrate mobility of the fungal ball 6, 5

Associated Findings

  • Pre-existing cavitary lung disease is almost always present (from tuberculosis, sarcoidosis, COPD, prior pneumothorax, or treated lung cancer) 1
  • Pleural thickening adjacent to the cavity 3
  • Upper lobe predominance is common, reflecting the typical location of underlying cavitary disease 1
  • Small aspergillomas can be identified that may be missed on conventional radiography 6

Important Caveats

  • The air crescent sign is not specific for aspergilloma and can be mimicked by pulmonary hydatid cyst, Rasmussen aneurysm, pulmonary gangrene, intracavitary clot, textiloma, lung cancer, metastasis, and teratoma 4
  • CT can help rule out fibrotic lesions previously attributed to mycetomas on conventional X-ray 6
  • The classic mobile fungus ball appearance is not the only definitive criterion—fixed sponge-work patterns are equally diagnostic in the appropriate clinical context 5
  • No CT technique is 100% sensitive or specific, and correlation with Aspergillus IgG antibodies (positive in >90% of cases) is essential for confirmation 1, 2

Diagnostic Confirmation

  • CT findings must be combined with positive Aspergillus IgG or precipitins testing for definitive diagnosis 1, 2
  • Virtually all patients with aspergilloma have serum precipitating antibodies to Aspergillus antigens 7
  • Bronchoscopy with bronchoalveolar lavage should be performed if clinically indicated, with samples sent for culture and galactomannan testing 2

Follow-up Imaging

  • Follow-up CT scans should be obtained after a minimum of 2-3 months of treatment to assess response 2
  • Low-dose CT protocols should be used for serial imaging to minimize radiation exposure 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach and Treatment for Suspected Aspergilloma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2001

Related Questions

What is the initial diagnostic approach and treatment for a patient suspected of having an Aspergiloma?
What is the recommended treatment and management approach for a patient with aspergilloma, potentially with underlying lung disease such as Chronic Obstructive Pulmonary Disease (COPD) or cystic fibrosis?
What are the lung exam findings in patients with aspergillosis?
What is the appropriate treatment for a patient with partially expanded lungs, prominent hilar vasculature, left lower lobe haze, and a few foci in the left upper lobe, suggestive of an infective etiology?
What are the radiologic findings in Aspergillosis (infection caused by Aspergillus fungus)?
Is it acceptable to nebulize Salbutamol (albuterol) and Adrenaline (epinephrine) together in a resource-limited Primary Health Centre setting for adult patients with undifferentiated acute wheeze, where it's challenging to differentiate between upper and lower airway wheeze?
What is the recommended treatment and management approach for a patient with aspergilloma, potentially with underlying lung disease such as Chronic Obstructive Pulmonary Disease (COPD) or cystic fibrosis?
When do I resume anticoagulation in a patient with atrial fibrillation (AF) who has experienced an ischemic stroke?
What are the indications, dosing, and potential side effects of Tirzepatide (a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist) for a patient with type 2 diabetes and impaired glycemic control?
What dietary recommendations are suggested for a patient with coronary artery disease (CAD)?
What are the potential interactions between thiocholchicoside and methotrexate (MTX) and tofacitinib in an adult patient with rheumatoid arthritis (RA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.